Besides, to make the comparisons among STMN1 and reported biomarkers, which can be used to predict the HCC prognosis or recurrence, including FN1, S100P, TSPAN12, MYC, WNK2, CD44, STIP1 [21–25], we analyzed the early stage HCC data in the TCGA and the uni- and multivariate cox regression analyses were both performed. The gene discussed is TSPAN12; the disease is hepatocellular carcinoma.